NEW AGENTS IN OVARIAN-CANCER

被引：2

作者：

SLAYTON, RE

机构：

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1982年 / 8卷 / 08期

关键词：

D O I：

10.1016/0360-3016(82)90595-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1431 / 1434

页数：4

共 32 条

[1]

ALBERTS DS, 1980, LANCET, V2, P340

[2]

BLOM J, 1980, P AM ASSOC CANC RES, V21, P416

[3]

BOLIS G, 1979, CANCER TREAT REP, V63, P1375

[4]

BONOMI PD, 1979, CANCER TREAT REP, V63, P137

[5]

BRUCKNER HW, 1978, CANCER TREAT REP, V62, P555

[6]

BRUCKNER HW, 1981, GYN ONC

[7]

DELGADO G, 1978, P AM ASSOC CANC RES, V19, P332

[8]

DOMBERNOWSKY P, 1980, P AM ASSOC CANC RES, V21, P426

[9] PHASE-II EVALUATION OF VP-16-213 (NSC-141540) IN PATIENTS WITH ADVANCED OVARIAN CARCINOMA RESISTANT TO ALKYLATING-AGENTS [J].

EDMONSON, JH ;

DECKER, DG ;

MALKASIAN, GD ;

WEBB, MJ ;

JORGENSEN, EO .

GYNECOLOGIC ONCOLOGY, 1978, 6 (01) :7-9

[10] PHASE 2 EVALUATION OF CYTEMBENA (NSC-104801) IN PATIENTS WITH ADVANCED OVARIAN CARCINOMA RESISTANT TO ALKYLATING-AGENTS - BRIEF COMMUNICATION [J].

EDMONSON, JH ;

DECKER, DG ;

MALKASIAN, GD ;

WEBB, MJ ;

JORGENSEN, EO .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 59 (06) :1619-1620

← 1 2 3 4 →